380 related articles for article (PubMed ID: 21527746)
1. Triglycerides and heart disease: still a hypothesis?
Goldberg IJ; Eckel RH; McPherson R
Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1716-25. PubMed ID: 21527746
[TBL] [Abstract][Full Text] [Related]
2. Triglyceride-Rich Lipoproteins and Their Remnants as Silent Promoters of Atherosclerotic Cardiovascular Disease and Other Metabolic Disorders: A Review.
Sascău R; Clement A; Radu R; Prisacariu C; Stătescu C
Nutrients; 2021 May; 13(6):. PubMed ID: 34067469
[TBL] [Abstract][Full Text] [Related]
3. Triglyceride-Rich Lipoprotein Remnants and Cardiovascular Disease.
Duran EK; Pradhan AD
Clin Chem; 2021 Jan; 67(1):183-196. PubMed ID: 33409533
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein B48 metabolism in chylomicrons and very low-density lipoproteins and its role in triglyceride transport in normo- and hypertriglyceridemic human subjects.
Björnson E; Packard CJ; Adiels M; Andersson L; Matikainen N; Söderlund S; Kahri J; Hakkarainen A; Lundbom N; Lundbom J; Sihlbom C; Thorsell A; Zhou H; Taskinen MR; Borén J
J Intern Med; 2020 Oct; 288(4):422-438. PubMed ID: 31846520
[TBL] [Abstract][Full Text] [Related]
5. Postprandial triglycerides and endothelial function.
Jagla A; Schrezenmeir J
Exp Clin Endocrinol Diabetes; 2001; 109(4):S533-47. PubMed ID: 11453041
[TBL] [Abstract][Full Text] [Related]
6. Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity.
Adiels M; Matikainen N; Westerbacka J; Söderlund S; Larsson T; Olofsson SO; Borén J; Taskinen MR
Atherosclerosis; 2012 May; 222(1):222-8. PubMed ID: 22365426
[TBL] [Abstract][Full Text] [Related]
7. The Role of Triglycerides in Atherosclerosis: Recent Pathophysiologic Insights and Therapeutic Implications.
Akivis Y; Alkaissi H; McFarlane SI; Bukharovich I
Curr Cardiol Rev; 2024; 20(2):39-49. PubMed ID: 38288833
[TBL] [Abstract][Full Text] [Related]
8. Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease.
Rosenson RS; Davidson MH; Hirsh BJ; Kathiresan S; Gaudet D
J Am Coll Cardiol; 2014 Dec; 64(23):2525-40. PubMed ID: 25500239
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants.
Grosskopf I; Baroukh N; Lee SJ; Kamari Y; Harats D; Rubin EM; Pennacchio LA; Cooper AD
Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2573-9. PubMed ID: 16166565
[TBL] [Abstract][Full Text] [Related]
10. Triglyceride-rich lipoproteins and cardiovascular diseases.
Xu D; Xie L; Cheng C; Xue F; Sun C
Front Endocrinol (Lausanne); 2024; 15():1409653. PubMed ID: 38883601
[TBL] [Abstract][Full Text] [Related]
11. Delayed clearance of chylomicron remnants following vitamin-A-containing oral fat loads in broad-beta disease (type III hyperlipoproteinemia).
Hazzard WR; Bierman EL
Metabolism; 1976 Jul; 25(7):777-801. PubMed ID: 181657
[TBL] [Abstract][Full Text] [Related]
12. Endogenous triglyceride-rich lipoproteins accumulate in rat plasma when competing with a chylomicron-like triglyceride emulsion for a common lipolytic pathway.
Karpe F; Hultin M
J Lipid Res; 1995 Jul; 36(7):1557-66. PubMed ID: 7595079
[TBL] [Abstract][Full Text] [Related]
13. Effects of a cardioselective beta-blocker on postprandial triglyceride-rich lipoproteins, low density lipoprotein particle size and glucose-insulin homeostasis in middle-aged men with modestly increased cardiovascular risk.
Boquist S; Ruotolo G; Hellénius ML; Danell-Toverud K; Karpe F; Hamsten A
Atherosclerosis; 1998 Apr; 137(2):391-400. PubMed ID: 9622282
[TBL] [Abstract][Full Text] [Related]
14. Determinants of fasting plasma triglyceride levels: metabolism of hepatic and intestinal lipoproteins.
Cortner JA; Le NA; Coates PM; Bennett MJ; Cryer DR
Eur J Clin Invest; 1992 Mar; 22(3):158-65. PubMed ID: 1582440
[TBL] [Abstract][Full Text] [Related]
15. Causes and Consequences of Hypertriglyceridemia.
Packard CJ; Boren J; Taskinen MR
Front Endocrinol (Lausanne); 2020; 11():252. PubMed ID: 32477261
[TBL] [Abstract][Full Text] [Related]
16. Role of high density lipoproteins in regulation of hepatic fatty acid synthesis by chylomicron and very low density lipoprotein remnants.
Lakshmanan MR; Maten MV; Muesing RA; O'Looney P; Vahouny GV
J Biol Chem; 1983 Apr; 258(8):4746-9. PubMed ID: 6833273
[TBL] [Abstract][Full Text] [Related]
17. Triglyceride-Rich Lipoproteins.
Kockx M; Kritharides L
Cardiol Clin; 2018 May; 36(2):265-275. PubMed ID: 29609756
[TBL] [Abstract][Full Text] [Related]
18. 2017 George Lyman Duff Memorial Lecture: Fat in the Blood, Fat in the Artery, Fat in the Heart: Triglyceride in Physiology and Disease.
Goldberg IJ
Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):700-706. PubMed ID: 29419410
[TBL] [Abstract][Full Text] [Related]
19. Severe defect in clearing postprandial chylomicron remnants in dialysis patients.
Weintraub M; Burstein A; Rassin T; Liron M; Ringel Y; Cabili S; Blum M; Peer G; Iaina A
Kidney Int; 1992 Nov; 42(5):1247-52. PubMed ID: 1453610
[TBL] [Abstract][Full Text] [Related]
20. Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma.
Björkegren J; Karpe F; Milne RW; Hamsten A
J Lipid Res; 1998 Jul; 39(7):1412-20. PubMed ID: 9684744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
